Immatics N.V. Ordinary Shares (IMTX) is a publicly traded Healthcare sector company. As of July 17, 2026, IMTX trades at $9.63 with a market cap of $1.29B and a P/E ratio of 0.00. IMTX moved +2.02% today. Year to date, IMTX is -10.48%; over the trailing twelve months it is +53.34%. Its 52-week range spans $3.30 to $12.41. Analyst consensus is strong buy with an average price target of $19.64. Rallies surfaces IMTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for IMTX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $9.63 |
| Market Cap | $1.29B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.41 |
| 52-Week Low | $3.30 |
| Volume | 214.35K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
6 analysts cover IMTX: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.64.